C.M. Bidwell & Associates’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $78.2K | Hold |
1,199
| – | – | 0.04% | 189 |
|
2025
Q1 | $80.3K | Sell |
1,199
-25
| -2% | -$1.67K | 0.05% | 174 |
|
2024
Q4 | $67.7K | Hold |
1,224
| – | – | 0.04% | 211 |
|
2024
Q3 | $73K | Buy |
1,224
+39
| +3% | +$2.33K | 0.04% | 204 |
|
2024
Q2 | $75.5K | Hold |
1,185
| – | – | 0.05% | 203 |
|
2024
Q1 | $81.9K | Hold |
1,185
| – | – | 0.06% | 199 |
|
2023
Q4 | $65.3K | Sell |
1,185
-2,081
| -64% | -$115K | 0.05% | 203 |
|
2023
Q3 | $190K | Buy |
3,266
+2,611
| +399% | +$152K | 0.14% | 121 |
|
2023
Q2 | $35.3K | Buy |
+655
| New | +$35.3K | 0.03% | 320 |
|